Reinsurance articles

A practical operating playbook for closing the cloud concentration gap before the next renewal, covering submission changes, technographic scanning, treaty wording, and ownership.

2026-09-08

Cloud concentration beyond named providers hides aggregation risk inside shared backend services that policy schedules never list, leaving cyber and technology reinsurers exposed to losses they never priced.

2026-09-08

Board risk committees need a specific set of questions to test whether management actually has visibility into cloud concentration beyond named providers before it becomes a correlated loss event.

2026-09-08

Cloud concentration beyond named providers forces reinsurance CEOs and CUOs to make explicit decisions about visibility investment, capacity deployment, and growth trade-offs before the next shared-infrastructure event.

2026-09-08

Cloud concentration beyond named providers turns one shared outage into many simultaneous claims, quietly eroding margin and distorting capital allocation across cyber and technology reinsurance books.

2026-09-08

Solving cyber event definitions across multiple treaties requires an operating control, not another one-off legal review after a loss.

2026-09-08

Cyber event definitions across multiple treaties often diverge just enough to distort aggregation, allocation, and underperformance analysis for reinsurers.

2026-09-08

Boards need a clear answer to what would break first if cyber event definitions across multiple treaties stayed ambiguous through the next systemic event.

2026-09-08

Executives making decisions on different versions of the same cyber event definitions across treaties are effectively negotiating with incomplete information.

2026-09-08

Mismatched cyber event definitions across multiple treaties inflate probable maximum loss estimates and quietly erode reinsurance return on capital.

2026-09-08

Health provider inflation hidden by network averages needs a repeatable operating process. Here is how to build a decision-ready view of provider price risk.

2026-09-08

Health provider inflation hidden by network averages leaves health reinsurers and cedants underpricing risk. Here is the executive-level diagnosis of that blind spot.

2026-09-08

Health provider inflation hidden by network averages raises capital allocation questions health reinsurers cannot answer with a blended discount figure alone.

2026-09-08

Boards overseeing health provider inflation hidden by network averages need a remediate, reprice, reduce, or exit test for underperforming provider exposures. Here is how to run it.

2026-09-08

Health provider inflation hidden by network averages forces leadership trade-offs between network breadth, price certainty, and treaty profitability. Here is how to weigh them.

2026-09-08

Catching longevity concentration across pension transactions before it becomes a capital problem takes an operating process built for aggregation, not just per-deal review. Here is how to build it.

2026-09-08

Longevity concentration across pension transactions builds quietly as large deals stack onto a small pool of reinsurers. Here is why the risk gets missed until it is already large.

2026-09-08

Boards overseeing life and health reinsurance need an explicit risk-appetite limit for longevity concentration across pension transactions, not just trust in transaction-level review. Here is the test to apply.

2026-09-08